IKS Health Launches MyCareHub Agentic AI Platform for Personalized Patient Engagement

IKS Health Launches MyCareHub Agentic AI Platform for Personalized Patient Engagement

IKS Health Launches MyCareHub Agentic AI Platform for Personalized Patient Engagement​

IKS Health, a global leader in care enablement solutions, has unveiled MyCareHub, an agentic AI self-orchestrating platform designed to revolutionize patient engagement throughout the entire healthcare journey. The launch was featured at the annual conference of the American Medical Group Association (AMGA) on April 15, 2026.

MyCareHub is a novel care model integrated with Epic and available in the Epic Connection Hub. The platform utilizes an active, aware, and constant multi-agent behavioral algorithm to create a patient engagement operating system that is adaptive, autonomous, and centered on the patient.

"MyCareHub is not the patient engagement tool of yesteryear," said Mayank Pant, executive vice president of product management at IKS Health. "It is a groundbreaking operating platform that is intelligence based and orchestrates interactions across the patient access lifecycle. We've built MyCareHub on the belief that prioritizing patients improves all other outcomes with a personalized and proactive experience that is compliant, efficient and continuously learning."

The platform leverages behavioral modeling, longitudinal patient memory, decision intelligence, orchestration logic, safety guardrails, and transparent autonomy controls to establish a new standard for patient engagement. It provides a nuanced score of a patient’s awareness of obligations, their ability to meet them, and their willingness to do so. The system customizes the channel, cadence, and tone of reminders to drive adherence, aiming to ensure quality care while lowering the total cost of care.

Proven Impact at OrthoNY​

IKS Health implemented MyCareHub at OrthoNY, a leading orthopedic and pain management practice located in the Capital Region of New York. Data gathered since the rollout in 2025 highlights a material improvement in key financial metrics.

Year-over-year comparison data from OrthoNY's MyCareHub platform showed:

MetricIncrease (%)
Total Patient Collections4.7%
Patient Payments Per Visit9.4%
Net Payments Per Visit8.25%

"It's clear that IKS Health's MyCareHub is purpose-built to put patients first while improving the overall visit experience," stated Lisa O'Connell, senior director of revenue cycle management at OrthoNY. "From first-visit onboarding through financial clearance and billing, patients report that the mobile-friendly platform delivers confidence, transparency and ease, from registration to payment."

Sachin K. Gupta, founder and global CEO of IKS Health, highlighted the strategic advantages of the technology. "By leveraging MyCareHub's agentic and predictive powers, healthcare organizations can understand their patients emotionally, clinically and financially. Our patient-first approach drives stronger engagement and creates intelligent anticipation that benefits patients, care teams and the long-term sustainability of healthcare organizations."

IKS Health aims to reduce the administrative, clinical, and operational burdens that slow healthcare down, enabling clinicians and care teams to focus on delivering exceptional care. Through its Care Enablement platform, the company integrates agentic AI workflows with human expertise to drive better outcomes and financially sustainable growth across the care journey.

IKS Stock Price Movement​

On Wednesday, Inventurus Knowledge Solutions Limited shares gained 0.20% to settle at ₹1517. The stock saw a trading range between ₹1494 and ₹1550, supported by a total volume of 331,517 shares.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top